Papillary carcinoma of thyroid
Conditions
Interventions
Prospective validation model group:None
Sponsors
The First Affiliated Hospital of Dalian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.T1-T2(=40mm) 2.cN0(undoubtedly positive lymph nodes before surgery) 3. Postoperative pathological diagnosis was PTC 4. Unilateral adenolobectomy combined with isthmus or total adenolobectomy combined with central lymph node dissection with evidence of central lymph node metastasis.
Exclusion criteria
Exclusion criteria: 1. Postoperative paraffin-embedded histology proved non-PTC or mixed PTC 2. No central lymph node dissection was performed 3. Evidence of blood disease 4. Evidence of autoimmune disease 5. There is evidence of acute and chronic inflammation or other diseases affecting blood routine examination before surgery 6. Pathological or clinical diagnosis of distant metastasis 7. Incomplete clinical data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neutrophils absolute value/lymphocytes absolute value;Platelet absolute value/lymphocyte absolute value;Lymphocyte absolute value/monocyte absolute value;Platelet absolute value × neutrophil absolute value/lymphocyte absolute value;Neutrophil calculation * Monocyte count/lymphocyte count = systemic inflammatory response Index;thyrotropin;ingredient;echo;Aspect ratio > 1;edge;calcification;position;Bilateral or unilateral;Single or multiple shots;Tumor size;Whether there is capsular invasion;Central lymph node metastasis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Thyroglobulin antibody;Thyroid peroxidase antibody;Thyrotropin receptor antibody; | — |
Countries
China
Contacts
Public ContactYing Che
The First Affiliated Hospital of Dalian Medical University
Outcome results
None listed